Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation independent delivery technology. Suono Bio’s platform enables rapid, localized delivery of small molecules, biologics, and nucleic acids and gene therapies without the need for encapsulation of the therapeutic. For more information, please visit www.suonobio.com
Location: United States, Massachusetts, Cambridge
Member count: 11-50
Total raised: $8.5M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Medical Techno... | medtechvp.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.07.2021 | Series A | $8.5M | - | finsmes.com/20... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 13.07.2021 | Suono Bio Rais... | Suono Bio, Inc., a Foxborough, Mass.-based advancing treatments of gastrointestinal diseases, raised... | finsmes.com/20... |
| 19.09.2017 | MIT’s The ... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints [Updated 9/20/17, 8:18 am. See bel... | xconomy.co... |